Benzonatate
- Product NDC
- 42192-617
- 11-digit product format
- 421920617
- Labeler code
- 42192
- Product ID
- 42192-617_1dbaffc9-a0dc-467e-a95e-6d2b9e8b7ccd
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Benzonatate
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Acella Pharmaceuticals, LLC
- Application
- ANDA091310
- Marketing category
- ANDA
- Marketing start
- 2021-08-02
- Marketing end
- 0000-00-00
- Substance
- BENZONATATE
- Active strength
- 100 mg/1
- Pharmacologic classes
- Decreased Tracheobronchial Stretch Receptor Activity [PE],Non-narcotic Antitussive [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 42192-617-01 | 42192061701 | 100 CAPSULE in 1 BOTTLE (42192-617-01) | 100 capsule | 2021-08-02 | 0000-00-00 | No | No | Current |
| 42192-617-05 | 42192061705 | 500 CAPSULE in 1 BOTTLE (42192-617-05) | 500 capsule | 2021-08-02 | 0000-00-00 | No | No | Current |